biotechinvestor1
15 minutes ago
Well said!
I have posted about her failure to deliver on her promises in 2023 multiple times on this board. That was why halozyme had a terrible year in 23 while the XBI and IBB did so well. With better performance in 2024, investors moves on. However, with this new major fumble, the